9th Annual Childhood Cancer Symposium
June 18, 2022
Virtual
DISCLOSURE INDEX
The Medical Educator Consortium, Inc. in accordance with the Joint Accreditation Criteria and the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, has implemented a process where everyone who is in a position to control the content of a CE activity has disclosed to us all relevant financial relationships with any ineligible company that they have had over the past 24 months. There is no minimum financial threshold; disclosure must be made regardless of whether the person views the financial relationships as relevant to the education. The ACCME defines an ineligible company as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. MEC has implemented a mechanism to identify, mitigate and disclose relevant financial relationships prior to the education activity being delivered to learners.
As a Joint Accreditation (JA) Provider, decisions in the planning process of this conference were made free of the control of ineligible companies. All individuals who are in a position to control the content of this educational activity have disclosed all relevant financial relationships with any ineligible companies to the provider. This disclosure includes all persons in control of content to include staff and educational committee members involved in the planning process.
The ACCME defines an ineligible company as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be ineligible companies.
Speakers/Moderators/Panelists– Reported Relevant Financial Disclosure(s)
Allison S. Bechtel, DO
Seth Berkowitz, MSW
Pam K. Bolton, MS
Michelle M. Bustamante, PharmD, BCPPS
Rosanne Elg
Ashwin Mehta, MD, MPH
Natalie Nathanson, JD
Have no relevant financial relationships
Planning Committee - Reported Relevant Financial Disclosure(s)
Barbara Abernathy, PhD
Allison S. Bechtel, DO
Seth Berkowitz, MSW
Pam K. Bolton, MS
Michelle M. Bustamante, PharmD, BCPPS
Lynne Davidson
Taumoha Ghosh, MD
Leslie Hutchins, MS Education
Lesley Klein, RD
Deborah L. Kramer, MD
Valerie Fiordilino Maslow, MMS, PA-C
Natalie Nathanson, JD
Jennifer Smith, BSN, RN
Dana Tabib, BS
Teri Valls, CMP, CMM
Lauren Walcott, MSW
Tung T. Wynn, MD
Have no relevant financial relationships
CME Reviewers - Reported Relevant Financial Disclosure(s)
Lynne Davidson
Deborah L. Kramer, MD
Teri Valls, CMP, CMM
Have no relevant financial relationships
No relevant financial relationships to mitigate for these individuals.
SPEAKERS WILL DIRECTLY DISCLOSE THE USE OF PRODUCTS FOR WHICH ARE NOT LABELED (E.G., OFF LABEL USE) OR IF THE PRODUCT IS STILL INVESTIGATIONAL. EACH SPEAKER HAS BEEN REQUESTED TO KEEP THEIR PRESENTATION UNBIASED AND GENERIC WHEN APPLICABLE.
